How does XVA get incorporated into a derivatives price?

When a client requests a price on a new OTC derivative, the sales desk sends the trade details to the XVA desk, which calculates the full XVA adjustment: CVA (counterparty credit risk), FVA (funding cost), MVA (initial margin cost), and KVA (regulatory capital cost). The sum of these adjustments is expressed as a running spread in basis points, which is added to or subtracted from the theoretical mid-market price. For a 5Y IRS, if the mid-market fixed rate is 4.55% and total XVA is 18bps, the bank offers 4.37% (receiving 18bps less than mid to cover XVA costs) or bids 4.73% if the client wants to pay fixed. The XVA adjustment makes the theoretical mid-market price economically meaningful — without it, banks would be giving away the credit, funding, and capital costs.

What determines the XVA bid/offer spread on a derivative?

The XVA bid/offer spread is the total of all XVA components (CVA, FVA, MVA, KVA), and each component depends on different inputs: CVA depends on the counterparty's credit quality (CDS spread/rating), trade tenor, and expected exposure profile. FVA depends on the bank's own funding spread and the degree of exposure that must be funded uncollateralized. MVA depends on whether the trade falls under UMR (is the aggregate AANA over €8B?) and the expected SIMM IM profile over the trade's life. KVA depends on regulatory capital requirements, the counterparty's credit risk weight, and the bank's cost of capital. For a short-dated FX forward with a IG corporate counterparty, XVA may be only a few basis points. For a long-dated XCCY swap with an HY corporate without CSA, XVA can exceed 100bps.

When is clearing economically better than bilateral for a client?

Clearing is economically better when: the XVA bid/offer on the bilateral trade (driven by CVA, FVA, KVA) exceeds the cost of clearing (CCP fees, IM funding cost / MVA). For IG corporate clients with existing CSA relationships, bilateral may remain cheaper because CVA and FVA are already low with daily margining, while clearing adds CCP fees and IM requirements. For HY corporates without CSA, bilateral CVA and KVA can be large enough that clearing is cheaper even after IM costs. The clearing break-even analysis compares: (bilateral CVA + bilateral FVA + bilateral KVA) vs. (clearing MVA + CCP fees + clearing KVA). The CVA exemption for cleared trades and the preferential CCP risk weight (2%) typically make clearing cheapest for rate-sensitive financial counterparties.

How does CSA presence change the XVA calculation?

A zero-threshold, daily-margined CSA eliminates almost all CVA (expected exposure falls to near zero over the MPoR) and most FVA (funding gap is covered by daily collateral receipts). MVA may increase (if the netting set triggers UMR). KVA falls significantly (SA-CCR EAD is much lower with collateral). Net effect: a good CSA typically reduces total XVA by 60-80% compared to uncollateralized bilateral. The residual XVA comes from the MPoR exposure (the 10-day window during which the bank is uncollateralized after the last margin call), threshold amounts, and MTA. This is why negotiating tight CSA terms (zero threshold, low MTA, daily margin calls) is economically valuable — it directly reduces the XVA charges passed to clients.

XVA in New Trade Pricing: RFQ, Bid/Offer, and Clearing Economics with Claude (2026)

XVA in derivatives trade pricing: full RFQ workflow, XVA bid/offer construction, incremental XVA for existing netting sets, clearing vs. bilateral economics, CSA-contingent pricing, and XVA competitiveness analysis. Worked Claude AI prompts.

Educational content, not professional advice — AI output and figures here can be wrong. Verify before you rely on it. Full disclaimer →

The Derivatives Pricing Chain: From Mid-Market to Client Quote

A vanilla OTC derivative has a theoretical mid-market price determined by arbitrage-free pricing: the present value of expected cash flows discounted at the appropriate risk-free (or OIS) curve. This price exists in a frictionless world where counterparty default is impossible, funding is costless, and capital is free. In reality, none of these are true. The XVA desk's job is to convert the theoretical mid-market price into an economically viable client quote by adding the real costs: credit risk (CVA), funding (FVA), initial margin (MVA), and capital (KVA).

Understanding this chain — from the risk-neutral mid-market price through XVA to a competitive client quote — is essential for anyone working in derivatives sales, structuring, or XVA. The chain determines whether a bank wins or loses a trade (XVA competitiveness), whether it makes money on the trade (XVA margin), and how to structure trades to minimize XVA for both the bank and client. Claude walks through the complete pricing chain for specific trades and helps compare alternative structures on an XVA basis. For component deep-dives see XVA Explained, SIMM and MVA, and KVA.

RFQ Process and XVA Workflow

The request for quote (RFQ) process for a standard OTC derivative typically runs as follows: (1) client calls or submits an electronic RFQ specifying the product, notional, tenor, and key terms; (2) sales desk captures the trade in the pricing system and routes to the XVA desk; (3) XVA desk calculates CVA, FVA, MVA, KVA in context with the existing netting set (incremental XVA for the new trade); (4) XVA charge is passed back to sales; (5) sales quotes the client with the XVA-adjusted price. For standardized products the whole process takes seconds; for structured or exotic trades it may take hours as the XVA desk models complex exposure profiles.

"XVA RFQ workflow for a 10Y USD IRS: Walk through the complete XVA calculation for a client RFQ: Client: A-rated US utility company. Trade: receive fixed 10Y USD IRS, $100M notional, SOFR-based floating leg. Existing relationship: CSA in place, zero threshold, daily VM, MTA $1M. Aggregate AANA with this counterparty: $2.8B — under the €8B UMR threshold (Phase 6), so no mandatory IM exchange. XVA components to calculate: (1) CVA — with daily VM CSA, expected exposure is limited to the MPoR (10 days). Compute CVA using 10-day peak exposure (95th percentile) × PD from A-rated spread (approximately 45bps) × LGD 40%. (2) FVA — daily VM eliminates funding gap on the bilateral trade; our hedge in the interbank market under a CSA also generates daily VM. Net FVA ≈ 0 for collateralized netting sets. (3) MVA — no SIMM IM required (under UMR threshold). MVA = 0. (4) KVA — SA-CCR EAD with zero-threshold CSA: MPoR-based exposure only. Compute CCR RWA (A-rated utility: 50% risk weight). CVA capital: BA-CVA on reduced regulatory CVA. Total KVA = CoC × K. Express all XVA components in bps spread."
"Incremental XVA for a new trade added to an existing netting set: We have an existing netting set with a BBB corporate: 3 pay-fixed IRS (5Y, 7Y, 10Y), aggregate MTM +$3.4M to us, EPE profile averaging $4.8M. Existing CVA on this netting set: $185K. The client now wants to add a new receive-fixed 3Y IRS, $40M. Incremental CVA = CVA(netting set + new trade) − CVA(existing netting set). (1) Compute the new EPE profile with the 3Y receive-fixed added — this reduces net DV01 and may reduce EPE. (2) Calculate CVA of the enlarged netting set. (3) Incremental CVA = new CVA − old CVA. (4) Explain why incremental XVA can be negative (the new trade reduces total CVA) and when this happens — when the new trade has negative correlation with existing exposure. (5) Express incremental XVA as a spread on the new trade's $40M notional."

Clearing vs. Bilateral: Full Economic Comparison

For eligible OTC derivatives (plain vanilla IRS, CDS index), clients and banks can choose between bilateral execution and CCP clearing. The economic comparison involves: bilateral XVA (CVA + FVA + MVA + KVA) vs. clearing economics (IM funding cost / MVA + CCP fees + clearing KVA). For most bank-to-corporate relationships, bilateral is cheaper when the corporate has a strong CSA in place; clearing becomes advantageous for HY counterparties without CSA, or for financial institution counterparties where bilateral CCR risk weights are higher.

"Clearing vs. bilateral economic comparison for a HY corporate client: Client: BB-rated energy company, no CSA currently in place. New trade: $50M 5Y pay-fixed USD IRS. Option A — Bilateral: CVA at 95th percentile exposure $6.2M, BB CDS spread 280bps, LGD 40% → CVA $72K ($72K/5Y/50M = 5.8bps/year). FVA on average positive exposure $4.1M, funding spread SOFR+60bps → FVA $24.6K/year = 2.0bps. KVA with SA-CCR EAD $8.4M, BB counterparty risk weight 150% (since BB below investment grade): CCR RWA $12.6M, CCR capital $1.0M/year. CVA capital $85K/year. KVA = ($1.0M + $85K) × 8% = $87K/year = 7.0bps. Total bilateral XVA = 14.8bps/year. Option B — Cleared at CME: SIMM IM profile: approximately $2.4M average → MVA = $2.4M × SOFR+60bps × 5Y PV = $72K/year = 5.8bps. CCR risk weight for QCCP: 2% → KVA_cleared = negligible. CVA exempt for cleared trades. CCP fees: 0.5bps/year. Total clearing cost = 6.3bps/year. Clearing saves 8.5bps/year. How does the comparison change if the client agrees to a zero-threshold CSA?"
"CSA-contingent pricing: same trade, different collateral terms: We are quoting a 7Y EUR/USD cross-currency basis swap to a BBB+ corporate client, €40M/USD notional. Quote the trade under three different collateral arrangements and show how the XVA changes: (1) No CSA — uncollateralized bilateral: full CVA (7Y EPE), full FVA, KVA on full EAD. (2) VM-only CSA (zero threshold, daily margining): CVA reduced to MPoR exposure only, FVA ≈ 0, KVA reduced. (3) VM + IM under UMR (client AANA > €8B): CVA as in (2), MVA on SIMM IM profile (XCCY swaps have both IR delta and FX delta SIMM exposure), KVA as in (2). Show the total XVA bid/offer spread for each arrangement and the clearing break-even (compare option 3 with CME clearing economics)."

XVA for Structured Products

Structured and exotic products present the greatest XVA challenges because their exposure profiles are nonlinear and path-dependent. A callable IRS (where the client can terminate early) has very different exposure dynamics from a plain vanilla equivalent — if the client calls when rates move in their favor, the bank loses the exposure that would have been generating CVA charges. Options, barriers, and callable features all change the shape of the expected exposure profile in ways that require simulation rather than closed-form approximation. XVA on structured products is typically computed using Monte Carlo simulation of the full market risk factor path.

"XVA impact of optionality in a callable IRS: We are pricing a 10Y callable pay-fixed USD IRS for a corporate client. The client wants the right to terminate the swap annually from year 3. Two scenarios: (A) Non-callable 10Y IRS: expected exposure profile rises for 5 years then declines. CVA = $X, KVA = $Y. (B) Callable 10Y IRS (Bermudan callable, annually from year 3): when the swap is deeply in the money to us (rates have fallen, fixed payment is valuable), the client is more likely to call the swap — precisely when we have high positive exposure. Explain: (1) how callability changes the expected exposure profile — does it increase or decrease CVA vs. non-callable, (2) the 'wrong-way-like' effect of callability on CVA — the optionality reduces exposure at exactly the time exposure is highest, which actually lowers CVA, (3) what does this mean for XVA pricing — should the callable IRS cost more or less XVA than the non-callable, (4) how does the bank hedge the CVA on a Bermudan callable — it cannot simply buy protection on a 10Y trade."

XVA Competitiveness and Winning Trades

Because XVA is computed differently by each bank (different cost of capital, different funding spread, different internal CVA models), XVA creates competitive differentiation beyond just the risk-free mid-market rate. A bank with a lower cost of capital quotes lower KVA; a bank with a tighter funding spread quotes lower FVA; a bank with a more efficient CSA structure quotes lower CVA. Banks that compete aggressively on XVA-intensive trades (long-dated cross-currency swaps with EM counterparties, uncollateralized IG corporates) are typically those with the lowest XVA cost base.

"XVA competitive analysis — why we lost an RFQ: We quoted a 7Y EUR cross-currency swap to an A-rated corporate at mid + 18bps XVA adjustment. A competitor won the trade at mid + 11bps. Decompose the potential sources of the 7bps gap: (1) CVA difference: if the competitor has a tighter CVA model for A-rated counterparties (e.g., they use internal ratings vs. our external rating-based approach), how much CVA differential is possible? (2) FVA difference: our funding spread is EURIBOR+65bps, competitor may fund at EURIBOR+40bps — what FVA difference does a 25bps funding spread advantage create on a €30M 7Y XCCY swap? (3) KVA difference: if competitor uses SA-CVA (with hedge recognition) and we use BA-CVA, what is the capital cost difference? (4) What structural changes could reduce our XVA below the competitor's quote — CSA improvement offer to client, netting set optimization, clearing?"

XVA Article Cluster

This article covers XVA in the trade pricing workflow. The full cluster covers every component with worked Claude prompts:

XVA Trading Desk AI — CVA desk workflows, CVA/DVA pricing, SA-CCR, SIMM estimation
XVA Explained: CVA, DVA, FVA, MVA, KVA — the full XVA framework with formulas
SA-CVA under FRTB — sensitivity-based CVA capital, hedge recognition, BA-CVA vs. SA-CVA
SIMM Initial Margin (UMR) — delta/vega/curvature, concentration thresholds, MVA pricing
Wrong-Way Risk in CVA — SWWR vs. GWWR, Basel III treatment, stress quantification
PFE and Expected Exposure — SA-CCR EAD, EPE/EEPE profiles, netting benefit, MPoR
XVA Greeks: CS01, IR01, FX01 — CVA sensitivity hedging, P&L attribution
Counterparty Credit Risk (Legal & Operational) — ISDA Master Agreement, CSA terms, close-out mechanics
KVA: Capital Valuation Adjustment — cost of capital in trade pricing, RoRWA, CCP economics
XVA Collateral Optimization — CTD collateral, IM minimization, collateral transformation
CVA Stress Testing — 2008/2022/Eurozone scenarios, reverse stress tests, ICAAP
FRTB Market Risk Capital — SA, IMA, NMRF, DRC, P&L attribution testing

Get free access